STOCK TITAN

Smith & Nephew plc - SNN STOCK NEWS

Welcome to our dedicated news page for Smith & Nephew plc (Ticker: SNN), a resource for investors and traders seeking the latest updates and insights on Smith & Nephew plc.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Smith & Nephew plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Smith & Nephew plc's position in the market.

Rhea-AI Summary
Smith+Nephew (SNN) announces the full commercial availability of its AETOS Shoulder System in the US, with 510(k) clearance for use with ATLASPLAN 3D Planning Software. The system aims to enhance total shoulder arthroplasty procedures, offering stability, flexibility, and streamlined instrumentation. Developed in partnership with Materialise NV, it received FDA clearance in June 2023, expanding Smith+Nephew's Upper Extremity portfolio.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
-
Rhea-AI Summary
Smith+Nephew unveils a glimpse into the future with its CORI Surgical System at AAOS 2024, showcasing a new feature to personalize surgery and enhance performance. The system offers robotic-assisted solutions for knee and hip arthroplasty, improving outcomes and cost-effectiveness. Personalized planning software powered by AI further enhances patient satisfaction and clinical outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
AI
-
Rhea-AI Summary
Smith+Nephew introduces CARTIHEAL AGILI-C Cartilage Repair Implant and REGENETEN Bioinductive Implant at AAOS Annual Meeting, revolutionizing soft tissue repair in Sports Medicine with proven clinical evidence.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
none
Rhea-AI Summary
Smith+Nephew (SN, SNN) announces impressive outcomes for its REGENETEN Bioinductive Implant from a recently completed randomized controlled trial. The trial demonstrated better tendon healing for rotator cuff tears compared to the standard of care, with a significantly lower re-tear rate and three times lower risk of re-tear. The REGENETEN Bioinductive Implant has had a transformative impact, offering a better solution for more than 1 million people having surgery for a rotator cuff tear each year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
none
-
Rhea-AI Summary
Smith+Nephew announces opening of Smith+Nephew Academy Munich, a new centre for surgical innovation and training.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.51%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.03%
Tags
none
Smith & Nephew plc

NYSE:SNN

SNN Rankings

SNN Stock Data

12.49B
865.34M
0.03%
7.65%
0.33%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
United Kingdom
Watford

About SNN

Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England.